+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Antidepressant"

Treatment Resistant Depression - Pipeline Insight, 2025 - Product Thumbnail Image

Treatment Resistant Depression - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Major Depressive Disorder - Pipeline Insight, 2025 - Product Thumbnail Image

Major Depressive Disorder - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Bipolar Disorder (Manic Depression)- Pipeline Insight, 2025 - Product Thumbnail Image

Bipolar Disorder (Manic Depression)- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Bipolar Depression - Pipeline Insight, 2025 - Product Thumbnail Image

Bipolar Depression - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Immune-Mediated Depression - Pipeline Insight, 2025 - Product Thumbnail Image

Immune-Mediated Depression - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Schizoaffective Disorder - Pipeline Insight, 2025 - Product Thumbnail Image

Schizoaffective Disorder - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
From
From
REXULTI Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

REXULTI Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • July 2023
  • 30 Pages
  • Global
From
From
From
United States and Japan LATUDA Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

United States and Japan LATUDA Market Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • United States, Japan United States, Japan
From
SPRAVATO Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

SPRAVATO Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • September 2022
  • 30 Pages
  • Global
From
From
From
Major Depressive Disorder - Epidemiology Forecast - 2032 - Product Thumbnail Image

Major Depressive Disorder - Epidemiology Forecast - 2032

  • Report
  • June 2022
  • 148 Pages
  • Global
From
Treatment Resistant Depression Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Treatment Resistant Depression Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
From
Major Depressive Disorder Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Major Depressive Disorder Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Loading Indicator

The Antidepressant market is a subset of the Mental Disorders Drugs market, which includes medications used to treat mental health conditions such as depression, anxiety, bipolar disorder, and schizophrenia. Antidepressants are the most commonly prescribed medications for treating depression, and are typically divided into two categories: selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs). These medications work by increasing the levels of serotonin and norepinephrine in the brain, which can help to improve mood and reduce symptoms of depression. Some of the major companies in the Antidepressant market include Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca, and Bristol-Myers Squibb. These companies produce a variety of antidepressants, including SSRIs and SNRIs, as well as other medications used to treat mental health conditions. Show Less Read more